Management of chronic myelogenous leukemia with COVID-19 and hepatitis B

Overview of attention for article published in Frontiers in oncology, August 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 7 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,700 followers.

RT @FrontOncology: New research: Management of chronic myelogenous leukemia with COVID-19 and hepatitis B: The application of immunosuppres…

12 Aug 2023

Reply Repost Favourite

New research: Management of chronic myelogenous leukemia with COVID-19 and hepatitis B: The application of immunosuppressive agents and targeted drugs has opened a novel approach for the treatment of hematological tumors, and the application of… #oncology

12 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.